Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genomic Investigation of Unusual Responders

NCT03740503 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT03740503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03740503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genomic Investigation of Unusual Responders
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2013
Completion date
November 30, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cancer, carcinoma of unknown primary, colorectal cancer, genitourinary cancer, gynecological cancer, melanoma (skin), non-small cell lung cancer, pancreatobiliary gastrointestinal cancer, rare cancer, upper aerodigestive tract cancer